Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 3/2014

Open Access 01-05-2014 | Original Article

Increased aortic stiffness and blood pressure in non-classic Pompe disease

Authors: Stephan C. A. Wens, Esther Kuperus, Francesco U. S. Mattace-Raso, Michelle E. Kruijshaar, Esther Brusse, Kees C. A. G. M. van Montfort, Marjan Scheltens- de Boer, Eric J. G. Sijbrands, Ans T. van der Ploeg, Pieter A. van Doorn

Published in: Journal of Inherited Metabolic Disease | Issue 3/2014

Login to get access

Abstract

Vascular abnormalities and glycogen accumulation in vascular smooth muscle fibres have been described in Pompe disease. Using carotid-femoral pulse wave velocity (cfPWV), the gold standard methodology for determining aortic stiffness, we studied whether aortic stiffness is increased in patients with Pompe disease. Eighty-four adult Pompe patients and 179 age- and gender-matched volunteers participated in this cross-sectional case-controlled study. Intima media thickness and the distensibility of the right common carotid artery were measured using a Duplex scanner. Aortic augmentation index, central pulse pressure, aortic reflexion time and cfPWV were assessed using the SphygmoCor® system. CfPWV was higher in patients than in volunteers (8.8 versus 7.4 m/s, p < 0.001). This difference was still present after adjustment for age, gender, mean arterial blood pressure (MAP), heart rate and diabetes mellitus (p = 0.001), and was shown by subgroup analysis to apply to the 40-59 years age group (p = 0.004) and 60+ years age group (p = 0.01), but not to younger age groups (p = 0.99). Except for a shorter aortic reflexion time (p = 0.02), indirect indicators of arterial stiffness did not differ between patients and volunteers. Relative to volunteers (20 %), more Pompe patients had a history of hypertension (36 %, p = 0.005), and the MAP was higher than in volunteers (100 versus 92 mmHg, p < 0.001). This study shows that patients with non-classic Pompe disease have increased aortic stiffness and blood pressure. Whether this is due to glycogen accumulation requires further investigation. To reduce the potential risk of cardiovascular diseases, we recommend that blood pressure and other common cardiovascular risk factors are monitored regularly.
Literature
go back to reference Balkestein EJ, van Aggel-Leijssen DP, van Baak MA, Struijker-Boudier HA, Van Bortel LM (1999) The effect of weight loss with or without exercise training on large artery compliance in healthy obese men. J Hypertens 17(12 Pt 2):1831–1835PubMedCrossRef Balkestein EJ, van Aggel-Leijssen DP, van Baak MA, Struijker-Boudier HA, Van Bortel LM (1999) The effect of weight loss with or without exercise training on large artery compliance in healthy obese men. J Hypertens 17(12 Pt 2):1831–1835PubMedCrossRef
go back to reference Braunsdorf WE (1987) Fusiform aneurysm of basilar artery and ectatic internal carotid arteries associated with glycogenosis type 2 (Pompe’s disease). Neurosurgery 21(5):748–749PubMedCrossRef Braunsdorf WE (1987) Fusiform aneurysm of basilar artery and ectatic internal carotid arteries associated with glycogenosis type 2 (Pompe’s disease). Neurosurgery 21(5):748–749PubMedCrossRef
go back to reference Collin C, Briet M, Tran TC et al (2012) Long-term changes in arterial structure and function and left ventricular geometry after enzyme replacement therapy in patients affected with Fabry disease. Eur J Prev Cardiol 19(1):43–54PubMed Collin C, Briet M, Tran TC et al (2012) Long-term changes in arterial structure and function and left ventricular geometry after enzyme replacement therapy in patients affected with Fabry disease. Eur J Prev Cardiol 19(1):43–54PubMed
go back to reference DeLoach SS, Townsend RR (2008) Vascular stiffness: its measurement and significance for epidemiologic and outcome studies. Clin J Am Soc Nephrol 3(1):184–192PubMedCrossRef DeLoach SS, Townsend RR (2008) Vascular stiffness: its measurement and significance for epidemiologic and outcome studies. Clin J Am Soc Nephrol 3(1):184–192PubMedCrossRef
go back to reference El-Gharbawy AH, Bhat G, Murillo JE et al (2011) Expanding the clinical spectrum of late-onset Pompe disease: dilated arteriopathy involving the thoracic aorta, a novel vascular phenotype uncovered. Mol Genet Metab 103(4):362–366PubMedCrossRef El-Gharbawy AH, Bhat G, Murillo JE et al (2011) Expanding the clinical spectrum of late-onset Pompe disease: dilated arteriopathy involving the thoracic aorta, a novel vascular phenotype uncovered. Mol Genet Metab 103(4):362–366PubMedCrossRef
go back to reference Girerd X, Giannattasio C, Moulin C, Safar M, Mancia G, Laurent S (1998) Regression of radial artery wall hypertrophy and improvement of carotid artery compliance after long-term antihypertensive treatment in elderly patients. J Am Coll Cardiol 31(5):1064–1073PubMedCrossRef Girerd X, Giannattasio C, Moulin C, Safar M, Mancia G, Laurent S (1998) Regression of radial artery wall hypertrophy and improvement of carotid artery compliance after long-term antihypertensive treatment in elderly patients. J Am Coll Cardiol 31(5):1064–1073PubMedCrossRef
go back to reference Güngör D, Kruijshaar ME, Plug I et al (2013) Impact of enzyme replacement therapy on survival in adults with Pompe disease: results from a prospective international observational study. Orphanet J Rare Dis 8(1):49PubMedCentralPubMedCrossRef Güngör D, Kruijshaar ME, Plug I et al (2013) Impact of enzyme replacement therapy on survival in adults with Pompe disease: results from a prospective international observational study. Orphanet J Rare Dis 8(1):49PubMedCentralPubMedCrossRef
go back to reference Hirschhorn, R. (2001) Glycogen storage disease type II: acid alpha- glucosidase (Acid Maltase) deficiency. The metabolic and molecular bases of inherited disease. In: Scriver CR, Sly WS, Valle D, New York, Mc Graw-Hill p3389-3420. Hirschhorn, R. (2001) Glycogen storage disease type II: acid alpha- glucosidase (Acid Maltase) deficiency. The metabolic and molecular bases of inherited disease. In: Scriver CR, Sly WS, Valle D, New York, Mc Graw-Hill p3389-3420.
go back to reference Hoeks AP, Brands PJ, Reneman RS (1992) Assessment of the arterial distension waveform using Doppler signal processing. J Hypertens Suppl 10(6):S19–S22PubMed Hoeks AP, Brands PJ, Reneman RS (1992) Assessment of the arterial distension waveform using Doppler signal processing. J Hypertens Suppl 10(6):S19–S22PubMed
go back to reference Huijben AM, Mattace-Raso FU, Deinum J, Lenders J, van den Meiracker AH (2012) Aortic augmentation index and pulse wave velocity in response to head-up tilting: effect of autonomic failure. J Hypertens 30(2):307–314PubMedCrossRef Huijben AM, Mattace-Raso FU, Deinum J, Lenders J, van den Meiracker AH (2012) Aortic augmentation index and pulse wave velocity in response to head-up tilting: effect of autonomic failure. J Hypertens 30(2):307–314PubMedCrossRef
go back to reference Kingwell BA, Berry KL, Cameron JD, Jennings GL, Dart AM (1997) Arterial compliance increases after moderate-intensity cycling. Am J Physiol 273(5 Pt 2):H2186–H2191PubMed Kingwell BA, Berry KL, Cameron JD, Jennings GL, Dart AM (1997) Arterial compliance increases after moderate-intensity cycling. Am J Physiol 273(5 Pt 2):H2186–H2191PubMed
go back to reference Kobayashi H, Shimada Y, Ikegami M et al (2010) Prognostic factors for the late onset Pompe disease with enzyme replacement therapy: from our experience of 4 cases including an autopsy case. Mol Genet Metab 100(1):14–19PubMedCrossRef Kobayashi H, Shimada Y, Ikegami M et al (2010) Prognostic factors for the late onset Pompe disease with enzyme replacement therapy: from our experience of 4 cases including an autopsy case. Mol Genet Metab 100(1):14–19PubMedCrossRef
go back to reference Laforet P, Petiot P, Nicolino M et al (2008) Dilative arteriopathy and basilar artery dolichoectasia complicating late-onset Pompe disease. Neurology 70(22):2063–2066PubMedCrossRef Laforet P, Petiot P, Nicolino M et al (2008) Dilative arteriopathy and basilar artery dolichoectasia complicating late-onset Pompe disease. Neurology 70(22):2063–2066PubMedCrossRef
go back to reference Laurent S, Cockcroft J, Van Bortel L et al (2006) Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 27(21):2588–2605PubMedCrossRef Laurent S, Cockcroft J, Van Bortel L et al (2006) Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 27(21):2588–2605PubMedCrossRef
go back to reference Mancia GR, Fagard K, Narkiewicz et al (2013) “2013 ESH/ESC Guidelines for the management of arterial hypertension.” Blood Press. Mancia GR, Fagard K, Narkiewicz et al (2013) “2013 ESH/ESC Guidelines for the management of arterial hypertension.” Blood Press.
go back to reference Mattace-Raso FU, van der Cammen TJ, Hofman A et al (2006) Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation 113(5):657–663PubMedCrossRef Mattace-Raso FU, van der Cammen TJ, Hofman A et al (2006) Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation 113(5):657–663PubMedCrossRef
go back to reference Nemes A, Soliman OI, Geleijnse ML et al (2007) Increased aortic stiffness in glycogenosis type 2 (Pompe’s disease). Int J Cardiol 120(1):138–141PubMedCrossRef Nemes A, Soliman OI, Geleijnse ML et al (2007) Increased aortic stiffness in glycogenosis type 2 (Pompe’s disease). Int J Cardiol 120(1):138–141PubMedCrossRef
go back to reference Nemes A, Timmermans RG, Wilson JH et al (2008) The mild form of mucopolysaccharidosis type I (Scheie syndrome) is associated with increased ascending aortic stiffness. Heart Vessels 23(2):108–111PubMedCrossRef Nemes A, Timmermans RG, Wilson JH et al (2008) The mild form of mucopolysaccharidosis type I (Scheie syndrome) is associated with increased ascending aortic stiffness. Heart Vessels 23(2):108–111PubMedCrossRef
go back to reference Paini A, Boutouyrie P, Calvet D, Tropeano AI, Laloux B, Laurent S (2006) Carotid and aortic stiffness: determinants of discrepancies. Hypertension 47(3):371–376PubMedCrossRef Paini A, Boutouyrie P, Calvet D, Tropeano AI, Laloux B, Laurent S (2006) Carotid and aortic stiffness: determinants of discrepancies. Hypertension 47(3):371–376PubMedCrossRef
go back to reference Sacconi S, Bocquet JD, Chanalet S, Tanant V, Salviati L, Desnuelle C (2010) Abnormalities of cerebral arteries are frequent in patients with late-onset Pompe disease. J Neurol 257(10):1730–1733PubMedCrossRef Sacconi S, Bocquet JD, Chanalet S, Tanant V, Salviati L, Desnuelle C (2010) Abnormalities of cerebral arteries are frequent in patients with late-onset Pompe disease. J Neurol 257(10):1730–1733PubMedCrossRef
go back to reference Soliman OI, van der Beek NA, van Doorn PA et al (2008) Cardiac involvement in adults with Pompe disease. J Intern Med 264(4):333–339PubMedCrossRef Soliman OI, van der Beek NA, van Doorn PA et al (2008) Cardiac involvement in adults with Pompe disease. J Intern Med 264(4):333–339PubMedCrossRef
go back to reference Thurberg BL, Lynch Maloney C, Vaccaro C et al (2006) Characterization of pre- and post-treatment pathology after enzyme replacement therapy for Pompe disease. Lab Invest 86(12):1208–1220PubMedCrossRef Thurberg BL, Lynch Maloney C, Vaccaro C et al (2006) Characterization of pre- and post-treatment pathology after enzyme replacement therapy for Pompe disease. Lab Invest 86(12):1208–1220PubMedCrossRef
go back to reference Van Bortel LM, Laurent S, Boutouyrie P et al (2012) Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens 30(3):445–448PubMedCrossRef Van Bortel LM, Laurent S, Boutouyrie P et al (2012) Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens 30(3):445–448PubMedCrossRef
go back to reference van den Hout HM, Hop W, van Diggelen OP et al (2003) The natural course of infantile Pompe’s disease: 20 original cases compared with 133 cases from the literature. Pediatrics 112(2):332–340PubMedCrossRef van den Hout HM, Hop W, van Diggelen OP et al (2003) The natural course of infantile Pompe’s disease: 20 original cases compared with 133 cases from the literature. Pediatrics 112(2):332–340PubMedCrossRef
go back to reference van der Beek NA, de Vries JM, Hagemans ML et al (2012) Clinical features and predictors for disease natural progression in adults with Pompe disease: a nationwide prospective observational study. Orphanet J Rare Dis 7:88PubMedCentralPubMedCrossRef van der Beek NA, de Vries JM, Hagemans ML et al (2012) Clinical features and predictors for disease natural progression in adults with Pompe disease: a nationwide prospective observational study. Orphanet J Rare Dis 7:88PubMedCentralPubMedCrossRef
go back to reference van Dijk SC, Smulders YM, Enneman AW et al (2013) Homocysteine level is associated with aortic stiffness in elderly: cross-sectional results from the B-PROOF study. J Hypertens 31(5):952–959PubMedCrossRef van Dijk SC, Smulders YM, Enneman AW et al (2013) Homocysteine level is associated with aortic stiffness in elderly: cross-sectional results from the B-PROOF study. J Hypertens 31(5):952–959PubMedCrossRef
go back to reference Verbeke F, Van Biesen W, Honkanen E et al (2011) Prognostic value of aortic stiffness and calcification for cardiovascular events and mortality in dialysis patients: outcome of the calcification outcome in renal disease (CORD) study. Clin J Am Soc Nephrol 6(1):153–159PubMedCentralPubMedCrossRef Verbeke F, Van Biesen W, Honkanen E et al (2011) Prognostic value of aortic stiffness and calcification for cardiovascular events and mortality in dialysis patients: outcome of the calcification outcome in renal disease (CORD) study. Clin J Am Soc Nephrol 6(1):153–159PubMedCentralPubMedCrossRef
go back to reference Winkel LP, Kamphoven JH, van den Hout HJ et al (2003) Morphological changes in muscle tissue of patients with infantile Pompe’s disease receiving enzyme replacement therapy. Muscle Nerve 27(6):743–751PubMedCrossRef Winkel LP, Kamphoven JH, van den Hout HJ et al (2003) Morphological changes in muscle tissue of patients with infantile Pompe’s disease receiving enzyme replacement therapy. Muscle Nerve 27(6):743–751PubMedCrossRef
go back to reference Winkel LP, Hagemans ML, van Doorn PA et al (2005) The natural course of non-classic Pompe’s disease; a review of 225 published cases. J Neurol 252(8):875–884PubMedCrossRef Winkel LP, Hagemans ML, van Doorn PA et al (2005) The natural course of non-classic Pompe’s disease; a review of 225 published cases. J Neurol 252(8):875–884PubMedCrossRef
Metadata
Title
Increased aortic stiffness and blood pressure in non-classic Pompe disease
Authors
Stephan C. A. Wens
Esther Kuperus
Francesco U. S. Mattace-Raso
Michelle E. Kruijshaar
Esther Brusse
Kees C. A. G. M. van Montfort
Marjan Scheltens- de Boer
Eric J. G. Sijbrands
Ans T. van der Ploeg
Pieter A. van Doorn
Publication date
01-05-2014
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 3/2014
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-013-9667-2

Other articles of this Issue 3/2014

Journal of Inherited Metabolic Disease 3/2014 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.